News

Cipla to enter into weight management segment in India, says MD Umang Vohra
The pharma major is also strengthening its presence in the central nervous system (CNS) therapeutic area, Vohra stated ...
‘Life-changing’: Wellington man back on weight loss drug after Medsafe approval
A Wellington man is stoked to finally get his hands back on the weight loss drug he said changed his life. Wegovy was ...
Nerve pain medication gabapentin possibly tied to dementia, study says
Gabapentin, which is used to treat seizures, nerve pain and restless leg syndrome might be linked with increased risk of ...
Novo Nordisk: The Market Doesn't Get It
Novo Nordisk's pipeline, especially the oral GLP-1 and Alzheimer’s trial, offers significant long-term upside. Click here to ...
Tyla1d
Potentially fatal effect of weight loss drugs prompts new investigation
Experts are warning anyone experiencing GLP-1 drug side effects to report them after launching an investigation into their safety.
The unexpected ways Ozempic-like drugs might fight dementia
They were designed to treat diabetes, then prescribed for weight loss, and now—as researchers are finding—they might hold the ...
FDA ends recall of salmonella-contaminated brown eggs
The federal government's investigation into a recall of Salmonella-contaminated brown cage-free and certified-organic eggs ...
Verywell Health2d
What Happens to Your Hair When You Take Weight-Loss Medications?
Some weight loss drugs may cause hair loss. While it’s typically a temporary side effect, it can affect your confidence.
Tyla2d
Ex-Ozempic user reveals ‘overwhelming’ side effects after increasing their dose despite ‘unbelievable’ first few months on it
The side effects of eating more than the small amount would lead him to become so bloated that he would burp twice every three minutes for hours, and they would smell like sulphur.
Dan Haar: Ozempic and Wegovy are expensive. Connecticut wants to make its own cheaper version.
The state law gives Gov. Lamont "an enormous amount of negotiating leverage with the industry," Sen. Lesser said.
The Darien Times2d
Dan Haar: Connecticut could make its own generic Ozempic under a new state law if Feds approve the plan
The state law gives Gov. Lamont "an enormous amount of negotiating leverage with the industry," Sen. Lesser said.
TMCnet3d
Kirby McInerney LLP Reminds Hims & Hers Health, Inc. (HIMS) Investors of Class Action Filing and Encourages Investors to Contact the Firm
The law firm of Kirby McInerney LLP reminds investors that a class action lawsuit has been filed in the U.S. District Court for the Northern District of California on behalf of those who acquired Hims ...